ANUPAMA PANT DHODAPKAR
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology LAKE JACKSON, TX NPI 1306863055
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$2,589.02
- Category: General Payments
- Program years: PY2018–2023
- Record count: 139
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $229.62 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.62 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $118.80 | 2 |
| Celgene Corporation | $28.74 | 1 |
| Regeneron Healthcare Solutions, Inc. | $25.32 | 1 |
| Genentech USA, Inc. | $20.50 | 1 |
| PFIZER INC. | $19.18 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.08 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1015699705 | Celgene Corporation | $28.74 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015699803 | E.R. Squibb & Sons, L.L.C. | $17.08 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1025523363 | Gilead Sciences, Inc. | $100.00 | 09/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1025862531 | Gilead Sciences, Inc. | $18.80 | 09/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1040303021 | Genentech USA, Inc. | $20.50 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1049807801 | PFIZER INC. | $19.18 | 09/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 999348021 | Regeneron Healthcare Solutions, Inc. | $25.32 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.